Remission of light chain proximal tubulopathy in IgG λ-type multiple myeloma by lenalidomide and dexamethasone therapy

被引:0
作者
Shinya Kawamoto
Yuji Hidaka
Yu Kaneko
Hideo Misawa
Katsuhiro Nagahori
Atsunori Yoshino
Takamitsu Okamura
Shinichi Ban
Yoshihiko Ueda
Tetsuro Takeda
机构
[1] Dokkyo Medical University Saitama Medical Center,Department of Nephrology
[2] Dokkyo Medical University Saitama Medical Center,Department of Internal Medicine
[3] Dokkyo Medical University Saitama Medical Center,Department of Pathology
来源
CEN Case Reports | 2019年 / 8卷
关键词
Light chain proximal tubulopathy; Multiple myeloma; IgG lambda M protein; Lenalidomide;
D O I
暂无
中图分类号
学科分类号
摘要
Light chain proximal tubulopathy is a rare manifestation of monoclonal gammopathy. A 73-year-old Japanese woman was noted to have urinary protein and hypertension on health examination and visited the regional clinic. She was noted to have IgG λ M protein and suspected of multiple myeloma. She was referred to us with massive proteinuria (7.5 g/g creatinine) and Bence Jones proteinuria without renal dysfunction. A renal biopsy revealed no glomerular abnormalities, but a tubular cast was observed partially in tubules without tubular atrophy or a crystalline structure. Direct Fast Scarlet staining was absent both in glomerulus and vascular wall. Immunofluorescence revealed λ light chain (LC) staining in the proximal tubules. Electron microscopy revealed nonspecific findings including increased lysosomes with irregular contours and mottled appearance. A bone marrow biopsy revealed plasma cell proliferation (35%) and multiple myeloma immunoglobulin G λ type. She showed progressive anemia and decrease of eGFR with elevated level of urinary β-2 microglobulin. She was treated with lenalidomide + dexamethasone (Ld). With Ld therapy, she achieved hematologic and nephrologic remission reducing the free LC, λ/κ ratio, urinary protein level, and urinary β-2 microglobulin level.
引用
收藏
页码:159 / 165
页数:6
相关论文
共 90 条
  • [1] Leung N(2014)Myeloma-related kidney disease Adv Chronic Kidney Dis 21 36-47
  • [2] Nasr SH(2003)Review of 1027 patients with newly diagnosed multiple myeloma Mayo Clin Proc 78 21-33
  • [3] Kyle RA(2012)Crystalline nephropathies Arch Pathol Lab Med 136 713-720
  • [4] Gertz MA(2011)The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation Mod Pathol 24 1462-1469
  • [5] Witzig TE(2014)Proximal tubulopathies associated with monoclonal light chains: the spectrum of clinicopathologic manifestations and molecular pathogenesis Arch Pathol Lab Med 138 1365-1380
  • [6] Herlitz LC(2016)Light chain proximal tubulopathy: clinical and pathologic characteristics in the modern treatment era J Am Soc Nephrol 27 1555-1565
  • [7] D’Agati VD(2016)Lambda light chain crystalline cast nephropathy and proximal tubulopathy Kidney Int Rep 1 316-320
  • [8] Markowitz GS(2017)A case of Fanconi syndrome due to light chain proximal tubulopathy J Jpn Soc Intern Med 106 813-817
  • [9] Larsen CP(2009)Light chain proximal tubulopathy Kidney Int 76 792-797
  • [10] Bell JM(1993)Monoclonal Ig L chain and L chain V domain fragment crystallization in myeloma-associated Fanconi syndrome J Immunol 150 3561-3568